Bryan Cave Helps Sigma-Aldrich In $350M Deal

Law360, New York (January 9, 2012, 12:32 PM EST) -- Science and technology company Sigma-Aldrich Corp. has expanded its reach into testing services, purchasing biopharmaceutical testing provider BioReliance Holdings Inc. from Avista Capital Partners for $350 million, the buyer announced Monday.

The companies said they have signed an agreement for the cash sale, expected to close in the first quarter of 2012, pending customary regulatory approvals.

St. Louis-based Sigma-Aldrich plans to fund the acquisition with a combination of existing cash and credit facilities, it said.

Sigma-Aldrich CEO Rakesh Sachdev said in a statement that he expected...
To view the full article, register now.